top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Anticancer Agents : Design, Synthesis and Evaluation
Anticancer Agents : Design, Synthesis and Evaluation
Autore Chen Qiao-Hong
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 electronic resource (606 p.)
Soggetto topico Medicine
Soggetto non controllato benzofurans
chemical synthesis
cytotoxic properties
HeLa
MOLT-4
K562
anticancer
anti-neuroinflammation
coumarin
dihydroartemisinin
flavonoids
allene
E-stereoselective
regioselective
anti-cancer activity
cyanopyridone
substituted pyridine
pyridotriazine
pyrazolopyridine
thioxotriazopyridine
anticancer activity
HepG2
antitumor activity
computational docking
MDM2-p53 interaction
xanthones
yeast-based assays
estrone derivatives
hydrazine
N-substituted pyrazoline
anti-ovarian cancer
topoisomerase II inhibitor
kinase inhibitor
antiproliferative agent
urea
synthesis
antiproliferative activity
apoptosis
indoleamine 2,3-dioxygenase
inhibitor
anti-tumor
immune modulation
tryptophan metabolism
taxoids
βIII-tubulin
P-glycoprotein
drug resistance
thiopene
thienopyrimidinone
thiazolidinone
breast cancer
benzofuran–pyrazole
nanoparticles
cytotoxic activity
PARP-1 inhibition
3,6-dibromocarbazole
5-bromoindole
carbazole
actin
migration
Thienopyrimidine
Pyrazole
PI3Kα inhibitor
quinazolin-4(3H)-one
quinazolin-4(3H)-thione
Schiff base
antioxidant activity
DFT study
ortho-quinones
beta-lapachone
tanshione IIA
PI3Ks
PI3Kδ inhibitors
2H-benzo[e][1,2,4]thiadiazine 1,1-dioxide
anticancer agents
protein–protein interactions
virtual screening
mimetics
drug discovery
bivalency
polyvalency
antitumor
cell cycle
ovarian cancer
P-MAPA
IL-12
TLR signaling
inflammation
chemoresistance
4-(pyridin-4-yloxy)benzamide
1,2,3-triazole
c-Met
natural product
anticancer agent
zampanolide
Talazoparib
PARP inhibitor
prodrug
o-nitro-benzyl
photoactivatable protecting groups
salinomycin
overcoming drug resistance
tumor specificity
synergy
5-fluorouracil
gemcitabine
amides/esters
colchicine analogs
thiocolchicine
colchiceine
antimitotic agents
hydrates
dihydropyranoindole
HDAC inhibitors
neuroblastoma
aromatase
MCF-7
NIH3T3
benzimidazole
triazolothiadiazine
docking
ADME
organosilicon compounds
SILA-409 (Alis-409)
SILA-421 (Alis-421)
multidrug resistance (MDR) reversal
ABCB1 (P-glycoprotein)
colon cancer
colchicine amide
colchicine sulfonamide
tubulin inhibitors
docking studies
crystal structure
PROTACs
protein degradation
IGF-1R
Src
protein kinase
phenylpyrazolopyrimidine
enzyme inhibition
molecular simulation
androgen receptor
prostate cancer
enzalutamide
apalutamide
darolutamide
triple-negative breast cancer
cytotoxicity
chrysin analogues
flavonoid
anticancer compounds
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Anticancer Agents
Record Nr. UNINA-9910557129103321
Chen Qiao-Hong  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Natural Product from the Deep Sea
Natural Product from the Deep Sea
Autore Umezawa Kazuo
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (116 p.)
Soggetto topico Medicine
Soggetto non controllato deep sea marine-derived fungus
Myrothecium sp
myrothecol
nitric oxide (NO)
antioxidant activity
macrolactam
Deep-Sea-Derived Streptomyces
abiotic formation
natural product
antifungal activity
Thorectandra choanoides
tryptophan alkaloid
indoleamine 2,3-dioxygenase
aplysinopsins
GNPS molecular network
cellular signal transduction
bioactive metabolite
deep-sea organisms
anti-inflammatory agent
anticancer agent
Mariana Trench
Micromonospora provocatoris MT25
desferrioxamine
n-acetylglutaminyl glutamine amide
1H-15N 2D-NMR
genomics
biosynthetic gene clusters
stress genes
crustins
antibacterial peptides
hydrothermal vent
anti-Gram-negative bacteria
Al-crus 3 and Al-crus 7
Trichoderma
harziane diterpenes
NO inhibition
thioester-containing benzoate
deep-sea-derived fungus
α-glucosidase inhibitory activity
docking study
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910566476303321
Umezawa Kazuo  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Outcomes and Therapeutic Management of Bladder Cancer
Outcomes and Therapeutic Management of Bladder Cancer
Autore Moschini Marco
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 electronic resource (120 p.)
Soggetto topico Medicine
Soggetto non controllato bladder cancer
robotic-assisted
open
radical cystectomy
survival
propensity score
age
urothelial carcinoma
outcome
anesthesia recovery periods
cognitive impairment
gamma-cyclodextrins
neuromuscular blockade
robotic radical cystectomy
glycogen
clear-cell adenocarcinoma
urinary bladder
SEER program database
female
intracorporeal neobladder
outcomes
robotic
sex-sparing
methylation
biomarkers
FOXA1
GATA3
KRT20
molecular markers
mRNA
muscle-invasive bladder cancer
PCR
human epidermal growth factor receptor 2
indoleamine 2,3-dioxygenase
programmed death ligand-1
immunotherapy
nodal disease
pN1
neoadjuvant
adjuvant
chemotherapy
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557114503321
Moschini Marco  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui